Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
131 hedge funds and large institutions have $296M invested in Spectrum Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 57 increasing their positions, 35 reducing their positions, and 25 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 35
0% less capital invested
Capital invested by funds: $297M → $296M (-$1.33M)
10% less funds holding
Funds holding: 146 → 131 (-15)
53% less call options, than puts
Call options by funds: $324K | Put options by funds: $692K
56% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$3.66M |
| 2 |
D.E. Shaw & Co
New York
|
+$1.29M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.23M |
| 4 |
TA
Teachers Advisors
New York
|
+$912K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$849K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$7.89M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.87M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.22M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.93M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.36M |
SPPI Hedge Fund Activity: Q1 2016 in Review
131 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2016, worth a combined $296M — down 0.45% from $297M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of SPPI and 11 opened new positions — a net loss of 14 holders — while 35 trimmed existing stakes and 57 added.
The largest buyer was Renaissance Technologies, adding an estimated $3.66M. The largest seller was State Street, cutting an estimated $7.89M.
- 131 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2016, down from 146 in Q4 2015.
- Funds reported $296M of Spectrum Pharmaceuticals Inc stock for Q1 2016, down 0.45% quarter-over-quarter.
- 11 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2016 and 25 closed out, a net change of -14 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q1 2016 was Renaissance Technologies, an estimated $3.66M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q1 2016 was State Street, an estimated $7.89M sold.
Based on aggregated 13F filings for Q1 2016.